跳至主要内容
临床试验/NL-OMON30325
NL-OMON30325尚未招募不适用

se of combined FDG-PET/CT in diagnosing infectious complications in patients treated with intensive chemotherapy and stem cell transplant recipients for haematological malignancy. - Diagnostic value of FDG-PET/CT in febrile neutropenia

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - admission and treatment at the department of hematology because of a hematological malignancy
  • - expected duration of neutropenia >7 days;and any of the following:
  • * C-reactive proteïn > 50 mg/l
  • * febrile neutropenia > 3-4 days despite aimed empirical or aimed antibiotic therapy
  • * persistant bacteraemia with coagulase negative Staphylococci
  • * pulmonary HRCT inidicated because of suspected pulmonary Aspergillosis

排除标准

  • - hemodynamic instablility
  • - diabetus millitus in which insulin has to be administered within 4 hours of the PET-scan either bloodglucose levels exceed 15 mmol.l
  • - pregnancy or lactation

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验